Narcotics scanners are devices used for detecting illicit drugs and narcotics. They help in identifying drugs through technology like trace detection and Raman spectroscopy without having to touch or open packages. With the rising drug crimes globally, narcotics scanners help law enforcement agencies efficiently screen individuals, vehicles and premises for drugs.
The global Narcotics Scanner Market is estimated to be valued at US$ 2735.68 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased funding and support from various government organizations is one of the key trends driving the growth of the narcotics scanner market. Governments across major economies are spending heavily on advanced screening technologies and devices to curb drug smuggling and abuse. For instance, in 2018, the US government allocated a budget of over US$ 12 billion for law enforcement agencies to procure full body scanners and narcotics trace detectors. Similarly, European commission has implemented new directives mandating installation of narcotics screening systems at major airports, borders and law enforcement checkpoints. Such initiatives are helping vendors expand their portfolio and geographical presence, thereby propelling the narcotics scanner market growth over the forecast period.
Segment Analysis
The global narcotics scanner market is dominated by tabletop narcotics scanners segment. Tabletop narcotics scanners are desktop devices that are easily portable and can be operated without extensive training. They provide fast and non-invasive screening of narcotics and are widely used by law and enforcement agencies at airports, railway stations, and border checkpoints for scanning luggage, parcels, and individuals in public places. Properties like compact design, ease of use, and cost-effectiveness have made tabletop narcotics scanners the most popular product type.
Key Takeaways
The global Narcotics Scanner Market Share is expected to witness high growth over the forecast period. The global Narcotics Scanner Market is estimated to be valued at US$ 2735.68 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2031.
North America currently dominates the market owing to stringent regulations regarding drug screening and high adoption of advanced screening technologies by law enforcement agencies in countries like the US and Canada. The market is expected to grow at the fastest rate in Asia Pacific due to rising drug trafficking and government initiatives to curb smuggling of illegal substances in countries like India and China. The presence of major players and adoption of advanced technologies have contributed to the region's leading position. Factors such as growing usage of narcotics, increasing trafficking of illegal substances, and stringent government regulations regarding drug screening are expected to drive the North American narcotics scanner market.
Key players
Key players operating in the narcotics scanner market include Akers Biosciences, Inc., Philips Healthcare, Abbott Laboratories, GE Healthcare, Nemaura Medical, Inc., Integrity Applications Inc., OrSense, MediWise Ltd., and Medtronic Plc. Akers Biosciences, Inc. offers a portable desktop narcotics scanner called TruNarc that provides rapid drug identification using Raman spectroscopy. Philips Healthcare provides desktop and handheld narcotics detection devices to identify illegal drugs and consumables.
For more insights, read- https://www.ukwebwire.com/narcotics-scanner-market-market-size-and-share-analysis/
For more details on the report, Read- https://whotimes.com/change-harmony-exploring-the-dynamic-world-of-ion-exchange-membranes-for-applications/
Comments
0 comment